PCSK1N and central nervous system cancer: Lower Kep was found associated with a favorable response to bevacizumab in recurrent high-grade glioma, and increased Kep was on the contrary associated with shorter PFS and OS [114,152], even if these observations have been not confirmed in other reports [40].